Send me real-time posts from this site at my email

Why iRhythm Technologies Stock Is Crashing Today

What happened

Shares of iRhythm Technologies (NASDAQ: IRTC) were crashing 37.5% lower as of 12:01 p.m. EDT on Monday. The big decline came after the company responded to the publication of Medicare reimbursement rates by Novitas Solutions on Saturday.

iRhythm stated that these new rates would negatively impact its first-quarter revenue by $13 million. The company also said it wouldn't be able to provide its Zio XT service for cardiac monitoring to the Medicare fee-for-service segment if the rates aren't increased.

Image source: Getty Images.

So what

Companies such as iRhythm are heavily dependent on the rates set by Medicare Administrative Contractors (MACs). It's not surprising that the healthcare stock would be hammered so hard after today's announcement.

iRhythm estimates that its full-year 2020 revenue would have been reduced by 15.6% if the rates recently set by Novitas had been in place throughout last year. The company said its gross margin would have fallen from 73.5% to 68.6%. In 2020, Medicare generated 27% of the company's total revenue.

Now what

iRhythm Technologies CEO Mike Coyle said, "We are extremely disappointed that Novitas did not reflect the appropriate clinical and economic value of long-term continuous ECG monitoring and Zio XT." The company said it's planning to discontinue serving this Medicare fee-for-service segment with its Zio XT service beginning in the second quarter.

However, iRhythm isn't completely giving up. Coyle said the company "will continue to work hard to secure more appropriate reimbursement for Medicare patients, including national pricing with CMS [Centers for Medicare and Medicaid Services], so we can continue to deliver the service to all potential patients who can benefit from it."

10 stocks we like better than iRhythm Technologies, Inc. Common Stock
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and iRhythm Technologies, Inc. Common Stock wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of February 24, 2021

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.


Source

Popular posts

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue